Checkmate Pharmaceuticals, Inc. - Common Stock (NQ:CMPI)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, May 27, 2022 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Checkmate Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 Next >

CHECKMATE PHARMACEUTICALS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Checkmate Pharmaceuticals, Inc. - CMPI

May 17, 2022

From Kahn Swick & Foti, LLC

Via Business Wire

CHECKMATE PHARMACEUTICALS INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Checkmate Pharmaceuticals, Inc. - CMPI

May 05, 2022

From Kahn Swick & Foti, LLC

Via Business Wire

The Week Ahead In Biotech (April 24-April 30): Bristol-Myers Squibb, Supernus, Hutchmed, Axsome, Coherus FDA Decisions, Big Pharma Earnings, IPOs And More ↗

April 24, 2022

Biotech stocks extended their loses in the week ending April 22. The sector took cues from the broader market, which reacted to the lackluster start of the first-quarter reporting season and lingering...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 20, 2022 ↗

April 20, 2022

Upgrades

Via Benzinga

Mid-Afternoon Market Update: Nasdaq Surges 200 Points; Dentsply Sirona Shares Plunge ↗

April 19, 2022

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Tuesday.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 19, 2022

Gainers Checkmate Pharmaceuticals (NASDAQ:CMPI) stock increased by 331.9% to $10.41 during Tuesday's regular session. Trading volume for Checkmate Pharmaceuticals'...

Via Benzinga

54 Biggest Movers From Yesterday ↗

April 20, 2022

Gainers Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) shares jumped 325.9% to close at $10.35 on Tuesday after Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced a deal to...

Via Benzinga

Why Is Arqit Quantum (ARQQ) Stock Down Today? ↗

April 19, 2022

Arqit Quantum (ARQQ) stock is slipping on Tuesday after former employees make allegations about the company's capabilities.

Via InvestorPlace

Dow Up Over 400 Points as Wall Street Pores Over Earnings ↗

April 19, 2022

Stocks are pointed higher this afternoon, as Wall Street pores over the latest batch of quarterly reports amid one of the busiest weeks of earnings season.

Via Talk Markets

Why Is Checkmate Pharmaceuticals (CMPI) Stock Up 300% Today? ↗

April 19, 2022

Checkmate Pharmaceuticals (CMPI) stock is rocketing higher on Tuesday following news that Regeneron Pharmaceuticals (REGN) is acquiring it.

Via InvestorPlace

Mid-Day Market Update: Crud Oil Down Over 5%; Checkmate Pharmaceuticals Shares Spike Higher ↗

April 19, 2022

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 200 points on Tuesday.

Via Benzinga

38 Stocks Moving In Tuesday's Mid-Day Session ↗

April 19, 2022

Gainers Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) climbed 329.2% to $10.43 after Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced a deal to acquire the company for $...

Via Benzinga

Mid-Morning Market Update: Markets Open Higher; Dow Jumps 400 Points ↗

April 19, 2022

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 400 points on Tuesday.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

April 19, 2022

Gainers Checkmate Pharmaceuticals (NASDAQ:CMPI) shares increased by 331.5% to $10.4 during Tuesday's pre-market session. The market value of their outstanding shares...

Via Benzinga

The Daily Biotech Pulse: Regeneron Acquires Checkmate Pharma, Moderna's Bivalent Booster COVID-19 Vaccine Update, Priority Review For AstraZeneca's Enhertu ↗

April 19, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

Checkmate Pharma Shares Skyrocket Over 300% On Regeneron $250M Acquisition Deal ↗

April 19, 2022

Via Benzinga

Why Checkmate Pharmaceuticals Shares Are Skyrocketing ↗

April 19, 2022

Checkmate Pharmaceuticals Inc (NASDAQ: CMPI) shares are trading higher by 328.40% to $10.41 during Tuesday's pre-market session after Regeneron Pharmaceuticals Inc (NASDAQ: REGN) announced a deal to...

Via Benzinga

CMPI Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Checkmate Pharmaceuticals, Inc. Is Fair to Shareholders

April 19, 2022

From Halper Sadeh LLP

Via Business Wire

The Daily Biotech Pulse: Aeglea Stock Jumps On Inherited Metabolic Disease Data, Partial Hold Lifted On Gilead's 2 Blood Trials, Early Data From Novartis' KRAS Inhibitor And More ↗

April 12, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

The Week Ahead In Biotech (April 10-April 16): Regeneron FDA Decision, Cancer Conference Presentations And More ↗

April 10, 2022

Biotech stocks managed to carve out modest gains for the week ending April 8, defying the broader market weakness. The defensive nature of the stocks make them appealing in times of risk aversion.

Via Benzinga

60 Biggest Movers From Yesterday ↗

February 10, 2022

Gainers US Ecology, Inc. (NASDAQ: ECOL) shares surged 67.7% to close at $47.25 on Wednesday after Republic Services reported it will buy the company at $48 per share in cash....

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

December 15, 2021

Gainers Calliditas Therapeutics (NASDAQ:

Via Benzinga

The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares ↗

November 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus J&J to Separate Its Consumer Health Business Into a New Publicly Traded...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

October 15, 2021

Gainers Sonoma Pharmaceuticals (NASDAQ:SNOA) shares moved upwards by 29.96% to $7.72 during Friday's pre-market session. The company's market cap stands at $20.8...

Via Benzinga

Why BofA Turned Bullish On Checkmate Pharmaceuticals, But Slashed Price Target ↗

October 06, 2021

Given the early clinical data on Checkmate Pharmaceuticals Inc’s (NASDAQ:

Via Benzinga

The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More ↗

November 08, 2021

Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out...

Via Benzinga

The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More ↗

October 24, 2021

Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2021 ↗

October 06, 2021

Upgrades According to TD Securities, the prior rating for Thomson Reuters Corp (NYSE:

Via Benzinga

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal ↗

October 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (...

Via Benzinga

The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout ↗

October 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 4) Avadel Pharmaceuticals plc (...

Via Benzinga

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.